{"id":26218,"date":"2022-10-14T13:05:15","date_gmt":"2022-10-14T13:05:15","guid":{"rendered":"https:\/\/celonpharma.com\/?p=26218"},"modified":"2022-11-30T13:14:21","modified_gmt":"2022-11-30T13:14:21","slug":"celon-pharma-na-kongresie-ecnp","status":"publish","type":"post","link":"https:\/\/celonpharma.com\/en\/celon-pharma-na-kongresie-ecnp\/","title":{"rendered":"Celon Pharma na \u00a0Kongresie\u00a0ECNP\u00a0"},"content":{"rendered":"\n

Celon Pharma na  Kongresie ECNP (European College of Neuropsychopharmacology).<\/p>\n\n\n\n

W trakcie konferencji zostan\u0105 zaprezentowane wyniki bada\u0144 przedklinicznych inhibitora PDE10a w obszarze dyskinez polewodopowych.<\/p>\n\n\n\n

Sesj\u0119 posterow\u0105 poprowadzi dr Miko\u0142aj Mat\u0142oka, a tytu\u0142 posteru to: <\/p>\n\n\n\n

“CPL500036 \u2013 a novel inhibitor of phosphodiesterase 10A \u2013 attenuates the development of L-DOPA-induced dyskinesias in 6-OHDA lesioned rats.” Prezentacja odb\u0119dzie si\u0119 we wtorek 18 pa\u017adziernika 13:00 – 14:20.<\/p>\n\n\n\n

ECNP to stowarzyszenie naukowe, zajmuj\u0105ce si\u0119 nauk\u0105 i leczeniem zaburze\u0144 m\u00f3zgu. Coroczny Kongres ECNP jest najwa\u017cniejszym europejskim spotkaniem naukowym po\u015bwi\u0119conym badaniom m\u00f3zgu, kt\u00f3re co roku przyci\u0105ga ponad 5000 psychiatr\u00f3w, neurolog\u00f3w, neurolog\u00f3w i psycholog\u00f3w z ca\u0142ego \u015bwiata.<\/p>\n\n\n\n

\"\"<\/figure>\n","protected":false},"excerpt":{"rendered":"

Celon Pharma na  Kongresie ECNP (European College of Neuropsychopharmacology). W trakcie konferencji zostan\u0105 zaprezentowane wyniki bada\u0144 przedklinicznych inhibitora PDE10a w obszarze dyskinez polewodopowych. Sesj\u0119 posterow\u0105 poprowadzi dr Miko\u0142aj Mat\u0142oka, a tytu\u0142 posteru to:  “CPL500036 \u2013 a novel inhibitor of phosphodiesterase 10A \u2013 attenuates the development of L-DOPA-induced dyskinesias in 6-OHDA lesioned rats.” Prezentacja odb\u0119dzie si\u0119 we wtorek 18 pa\u017adziernika 13:00Read more »<\/a><\/p>\n","protected":false},"author":31,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[27],"tags":[],"class_list":["post-26218","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"\nCelon Pharma na \u00a0Kongresie\u00a0ECNP\u00a0 - Celon Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celonpharma.com\/en\/celon-pharma-na-kongresie-ecnp\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celon Pharma na \u00a0Kongresie\u00a0ECNP\u00a0 - Celon Pharma\" \/>\n<meta property=\"og:description\" content=\"Celon Pharma na  Kongresie ECNP (European College of Neuropsychopharmacology). W trakcie konferencji zostan\u0105 zaprezentowane wyniki bada\u0144 przedklinicznych inhibitora PDE10a w obszarze dyskinez polewodopowych. Sesj\u0119 posterow\u0105 poprowadzi dr Miko\u0142aj Mat\u0142oka, a tytu\u0142 posteru to:  “CPL500036 \u2013 a novel inhibitor of phosphodiesterase 10A \u2013 attenuates the development of L-DOPA-induced dyskinesias in 6-OHDA lesioned rats.” Prezentacja odb\u0119dzie si\u0119 we wtorek 18 pa\u017adziernika 13:00Read more »\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celonpharma.com\/en\/celon-pharma-na-kongresie-ecnp\/\" \/>\n<meta property=\"og:site_name\" content=\"Celon Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-14T13:05:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-11-30T13:14:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/celonpharma.com\/wp-content\/uploads\/2022\/10\/CELON_LI_202210_43-1024x535.png\" \/>\n<meta name=\"author\" content=\"Paulina Dobies\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paulina Dobies\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-na-kongresie-ecnp\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-na-kongresie-ecnp\\\/\"},\"author\":{\"name\":\"Paulina Dobies\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/e86806fa37010f6a01f6fc388950174b\"},\"headline\":\"Celon Pharma na \u00a0Kongresie\u00a0ECNP\u00a0\",\"datePublished\":\"2022-10-14T13:05:15+00:00\",\"dateModified\":\"2022-11-30T13:14:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-na-kongresie-ecnp\\\/\"},\"wordCount\":123,\"image\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-na-kongresie-ecnp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/CELON_LI_202210_43-1024x535.png\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-na-kongresie-ecnp\\\/\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-na-kongresie-ecnp\\\/\",\"name\":\"Celon Pharma na \u00a0Kongresie\u00a0ECNP\u00a0 - Celon Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-na-kongresie-ecnp\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-na-kongresie-ecnp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/CELON_LI_202210_43-1024x535.png\",\"datePublished\":\"2022-10-14T13:05:15+00:00\",\"dateModified\":\"2022-11-30T13:14:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/e86806fa37010f6a01f6fc388950174b\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-na-kongresie-ecnp\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-na-kongresie-ecnp\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-na-kongresie-ecnp\\\/#primaryimage\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/CELON_LI_202210_43-1024x535.png\",\"contentUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/CELON_LI_202210_43-1024x535.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-na-kongresie-ecnp\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celon Pharma na \u00a0Kongresie\u00a0ECNP\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\",\"name\":\"Celon Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/e86806fa37010f6a01f6fc388950174b\",\"name\":\"Paulina Dobies\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celon Pharma na \u00a0Kongresie\u00a0ECNP\u00a0 - Celon Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celonpharma.com\/en\/celon-pharma-na-kongresie-ecnp\/","og_locale":"en_US","og_type":"article","og_title":"Celon Pharma na \u00a0Kongresie\u00a0ECNP\u00a0 - Celon Pharma","og_description":"Celon Pharma na  Kongresie ECNP (European College of Neuropsychopharmacology). W trakcie konferencji zostan\u0105 zaprezentowane wyniki bada\u0144 przedklinicznych inhibitora PDE10a w obszarze dyskinez polewodopowych. Sesj\u0119 posterow\u0105 poprowadzi dr Miko\u0142aj Mat\u0142oka, a tytu\u0142 posteru to:  “CPL500036 \u2013 a novel inhibitor of phosphodiesterase 10A \u2013 attenuates the development of L-DOPA-induced dyskinesias in 6-OHDA lesioned rats.” Prezentacja odb\u0119dzie si\u0119 we wtorek 18 pa\u017adziernika 13:00Read more »","og_url":"https:\/\/celonpharma.com\/en\/celon-pharma-na-kongresie-ecnp\/","og_site_name":"Celon Pharma","article_published_time":"2022-10-14T13:05:15+00:00","article_modified_time":"2022-11-30T13:14:21+00:00","og_image":[{"url":"https:\/\/celonpharma.com\/wp-content\/uploads\/2022\/10\/CELON_LI_202210_43-1024x535.png","type":"","width":"","height":""}],"author":"Paulina Dobies","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Paulina Dobies","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-na-kongresie-ecnp\/#article","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-na-kongresie-ecnp\/"},"author":{"name":"Paulina Dobies","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/e86806fa37010f6a01f6fc388950174b"},"headline":"Celon Pharma na \u00a0Kongresie\u00a0ECNP\u00a0","datePublished":"2022-10-14T13:05:15+00:00","dateModified":"2022-11-30T13:14:21+00:00","mainEntityOfPage":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-na-kongresie-ecnp\/"},"wordCount":123,"image":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-na-kongresie-ecnp\/#primaryimage"},"thumbnailUrl":"https:\/\/celonpharma.com\/wp-content\/uploads\/2022\/10\/CELON_LI_202210_43-1024x535.png","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-na-kongresie-ecnp\/","url":"https:\/\/celonpharma.com\/en\/celon-pharma-na-kongresie-ecnp\/","name":"Celon Pharma na \u00a0Kongresie\u00a0ECNP\u00a0 - Celon Pharma","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-na-kongresie-ecnp\/#primaryimage"},"image":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-na-kongresie-ecnp\/#primaryimage"},"thumbnailUrl":"https:\/\/celonpharma.com\/wp-content\/uploads\/2022\/10\/CELON_LI_202210_43-1024x535.png","datePublished":"2022-10-14T13:05:15+00:00","dateModified":"2022-11-30T13:14:21+00:00","author":{"@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/e86806fa37010f6a01f6fc388950174b"},"breadcrumb":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-na-kongresie-ecnp\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celonpharma.com\/en\/celon-pharma-na-kongresie-ecnp\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-na-kongresie-ecnp\/#primaryimage","url":"https:\/\/celonpharma.com\/wp-content\/uploads\/2022\/10\/CELON_LI_202210_43-1024x535.png","contentUrl":"https:\/\/celonpharma.com\/wp-content\/uploads\/2022\/10\/CELON_LI_202210_43-1024x535.png"},{"@type":"BreadcrumbList","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-na-kongresie-ecnp\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celonpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Celon Pharma na \u00a0Kongresie\u00a0ECNP\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/celonpharma.com\/en\/#website","url":"https:\/\/celonpharma.com\/en\/","name":"Celon Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celonpharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/e86806fa37010f6a01f6fc388950174b","name":"Paulina Dobies"}]}},"_links":{"self":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/26218","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/users\/31"}],"replies":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/comments?post=26218"}],"version-history":[{"count":2,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/26218\/revisions"}],"predecessor-version":[{"id":27106,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/26218\/revisions\/27106"}],"wp:attachment":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media?parent=26218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/categories?post=26218"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/tags?post=26218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}